V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009475 | 190004913 | 1.61 | 32.5 | Palliative (P) | 2016-07-06 | 2016-07-13 | DHAP | 01 | N | CISPLATIN + GEMCITABINE | 101755166 |
| 190009493 | 190004914 | 1.75 | 36.1 | null | 2018-12-10 | 2018-12-31 | NB Rel GD2ch14.18/CHO, IL-2 Isotret | 02 | Y | CARBOPLATIN + ETOPOSIDE | 101369193 |
| 190009496 | 190004915 | 1.54 | 102 | Palliative (P) | 2018-06-14 | 2018-06-15 | METHOTREXATE | 02 | N | METHOTREXATE | 100798783 |
| 190009503 | 190004916 | 0 | 23.6 | Palliative (P) | 2020-01-21 | 2020-01-21 | VAI (Ifos 3g/m2) | 01 | N | DOXORUBICIN + OLARATUMAB | 100485177 |
| 190009505 | 190004917 | 1.38 | 48.4 | Neo-adjuvant (N) | null | 2018-08-12 | EW EuroEwing 2012 Arm A VAI | 02 | null | TRIAL | 100154257 |
| 190009510 | 190004918 | 1.74 | 31.3 | Curative (C) | 2016-10-24 | 2016-11-09 | Gemcitabine + Capecitabine | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100547892 |
| 190009511 | 190004919 | 1.64 | 34.9 | Curative (C) | 2018-05-04 | 2018-05-11 | null | 02 | N | DHAP | 101066893 |
| 190009512 | 190004920 | 1.85 | 32.1 | Curative (C) | null | 2018-05-27 | EW EuroEwing 2012 Arm A VAC | 02 | N | NOT MATCHED | 101738123 |
| 190009516 | 190004921 | null | 90 | 03 | 2019-06-05 | 2019-06-23 | TEMOZOLOMIDE | 02 | N | VINCRISTINE | 101835370 |
| 190009517 | 190004922 | 1.58 | 57.3 | Curative (C) | 2017-05-18 | 2017-05-21 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B CE | 101378397 |
| 190009519 | 190004923 | 1.61 | 61 | null | 2018-04-02 | 2018-04-05 | EOX | 02 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 101706024 |
| 190009522 | 190004924 | 1.66 | 67.3 | null | null | 2020-05-28 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 101045682 |
| 190009532 | 190004925 | 1.7 | 88 | Palliative (P) | 2016-08-10 | 2016-09-01 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100808837 |
| 190009533 | 190004926 | 1.76 | 60.9 | Curative (C) | 2016-05-26 | 2016-05-26 | Capecitabine + Cisplatin | 01 | N | NB HRNBL-1 ISOTRETINOIN | 101239574 |
| 190009534 | 190004927 | null | 71.15 | Curative (C) | 2019-09-07 | 2019-10-03 | Imatinib 600mg | 02 | N | OST MIFAMURTIDE | 100158036 |
| 190009543 | 190004928 | 0 | 24.6 | null | 2020-01-16 | 2020-01-16 | Cisplatin + Etoposide (5 day) | N | null | NOT MATCHED | 101218469 |
| 190009544 | 190004929 | 1.74 | 54 | Curative (C) | 2018-08-01 | 2018-08-07 | OST Euramos 1 Closed Trial - A | 02 | null | OST A | 100979755 |
| 190009547 | 190004930 | 0 | 51 | Adjuvant (A) | 2017-11-24 | 2017-12-23 | EW EuroEwing 2012 Arm B IE | 02 | N | CISPLATIN | 101582623 |
| 190009548 | 190004931 | 0 | 26.5 | Neo-adjuvant (N) | 2016-11-10 | 2016-11-23 | METHOTREXATE | 02 | null | METHOTREXATE | 100759437 |
| 190009551 | 190004932 | 1.76 | 67.8 | null | 2017-11-01 | 2018-07-14 | CISPLATIN + GEMCITABINE | 01 | N | CISPLATIN + DOXORUBICIN | 101372859 |
| 190009556 | 190004933 | null | 109 | Curative (C) | 2020-03-02 | 2020-03-02 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100498543 |
| 190009561 | 190004934 | 1.8 | 68.4 | Curative (C) | null | 2020-01-09 | Docetaxel | null | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101277746 |
| 190009566 | 190004935 | 1.67 | 88 | null | 2019-08-19 | 2019-08-27 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100417776 |
| 190009570 | 190004936 | 1.87 | 95.95 | Palliative (P) | 2021-04-13 | 2021-04-13 | ETOPOSIDE + IFOSFAMIDE + MESNA | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100245391 |
| 190009573 | 190004937 | 1.64 | 76 | null | 2019-01-22 | 2019-01-22 | OST Euramos 1 Closed Trial - M | N | N | OST M | 100290138 |
| 190009576 | 190004938 | 1.79 | 50 | Curative (C) | 2018-03-19 | 2018-03-27 | Methotrexate High Dose (3g/m2) | Y | N | METHOTREXATE | 101692741 |
| 190009580 | 190004939 | 1.69 | 77.6 | Adjuvant (A) | 2018-06-23 | 2018-12-30 | EW EuroEwing 2012 Arm A VAI | 02 | N | CISPLATIN + DOXORUBICIN | 101149101 |
| 190009586 | 190004940 | 1.55 | 0 | Adjuvant (A) | 2018-04-30 | 2018-05-09 | EW EuroEwing 2012 Arm B VC | 02 | null | EW EUROEWING 2012 ARM B VC | 100381543 |
| 190009594 | 190004941 | 0 | 46.8 | null | null | 2017-01-21 | PEMBROLIZUMAB | null | null | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100690052 |
| 190009596 | 190004942 | 1.8 | 65 | null | null | 2021-03-20 | ETOPOSIDE + IFOSFAMIDE | 02 | Y | ETOPOSIDE + IFOSFAMIDE | 101696932 |
| 190009597 | 190004943 | 1.62 | 62.2 | null | null | 2019-12-28 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100821079 |
| 190009601 | 190004944 | 1.66 | null | Palliative (P) | null | 2021-01-23 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100331644 |
| 190009602 | 190004945 | 1.43 | 41 | Palliative (P) | null | 2016-03-07 | Etoposide + Ifosfamide (3 days) | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101469071 |
| 190009605 | 190004946 | 0 | 36.9 | null | null | 2016-08-27 | NIVOLUMAB | null | null | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 101617699 |
| 190009606 | 190004947 | 1.74 | 64 | Palliative (P) | 2017-02-28 | 2017-03-25 | Trial Unspecified | 02 | null | OST REL IFOSFAMIDE ETOPOSIDE | 100928300 |
| 190009610 | 190004948 | 1.85 | 76.1 | Curative (C) | 2018-04-08 | 2018-04-18 | Docetaxel + Gemcitabine with GCSF | 02 | Y | DOCETAXEL + GEMCITABINE | 100120986 |
| 190009614 | 190004949 | 0 | 88 | null | 2017-05-18 | 2017-05-19 | null | N | N | NB HRNBL-1 COJEC IND COURSE B | 100647864 |
| 190009619 | 190004950 | 0 | 30.1 | null | 2018-08-26 | 2018-08-26 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100675442 |
| 190009632 | 190004952 | 0 | 26.5 | Palliative (P) | 2019-11-23 | 2019-12-03 | null | 02 | N | CISPLATIN | 101186771 |
| 190009636 | 190004953 | 1.75 | 72.8 | null | 2020-08-14 | 2020-08-14 | EW EuroEwing 2012 Arm A VAI | 02 | N | ETOPOSIDE | 100342245 |
| 190009640 | 190004954 | 1.69 | 72.1 | Palliative (P) | 2016-09-23 | 2016-09-24 | OST Euramos 1 Closed Trial - M | 02 | Y | OST M | 100761425 |
| 190009650 | 190004955 | 0 | 87 | Palliative (P) | 2018-12-30 | 2019-04-22 | CT7001 | null | null | EURAMOS TRIAL | 101732192 |
| 190009651 | 190004956 | 1.75 | 82 | null | 2016-09-05 | 2016-09-05 | EW EuroEwing 2012 Arm B IE | 02 | Y | EW EUROEWING 2012 ARM B IE | 101343658 |
| 190009655 | 190004957 | 1.71 | 37.2 | Curative (C) | 2019-10-09 | 2019-10-14 | GemCarbo Days 1+8 | 02 | N | NOT MATCHED | 101178161 |
| 190009658 | 190004958 | 1.81 | 22.1 | Adjuvant (A) | 2018-10-22 | 2018-11-11 | Dox + HD Mtx (post PAM) | 02 | null | METHOTREXATE HIGH DOSE | 101249931 |
| 190009668 | 190004959 | 1.97 | 42 | Palliative (P) | 2019-07-19 | 2020-01-12 | CABOZANTINIB | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100473939 |
| 190009672 | 190004960 | 1.81 | 67.4 | null | 2021-03-23 | 2021-03-23 | STS Rhabdo RMS 2005 2nd Topo Cyclo | N | Y | CABOZANTINIB | 101535946 |
| 190009681 | 190004961 | 1.68 | null | Curative (C) | 2017-02-01 | 2017-02-12 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101583126 |
| 190009683 | 190004962 | 1.83 | 75.5 | Curative (C) | 2018-01-09 | 2018-01-29 | CAPECITABINE + OXALIPLATIN | 02 | N | PACLITAXEL | 101823405 |
| 190009697 | 190004963 | 1.79 | 96 | Neo-adjuvant (N) | 2020-12-29 | 2020-12-29 | Gemcitabine day 1&8 | 02 | N | DINUTUXIMAB BETA | 101837941 |